Stock price when the opinion was issued
The company is small at $900M, even with a double this year, but priced very well at 8X earnings. Q1 earnings were very strong, and resulted in multiple broker upgrades. The balance sheet has net cash, and good earnings growth is expected over the next two years. It has lost money in prior years, and earnings can be volatile. Insiders own 15% and have been net buyers this year. Overall, it looks quite good to us for a small cap in the insurance sector.
Unlock Premium - Try 5i Free
As analysts praise the super-regional insurance provider going for risk mitigation versus policy growth, we reiterate HRTG as a TOP PICK. The decision to exit high risk markets is aiding the bottom line allowing cash reserves to grow while debt is retired. It trades at 9x earnings, 2.1x book and supports a ROE of 27%. We recommend trailing up the stop (from $15.50) to $17.00, looking to achieve $29.00 -- upside potential of 28%. Yield 0%
(Analysts’ price target is $29.00)